reviewTop 1% cited
The EGFR as a target for anticancer therapy—focus on cetuximab
European Journal of Cancer · 2001 · Vol. 37 · pp. 16–22
José Baselga✉(Hebron University)
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchMedical Imaging Techniques and ApplicationsCetuximabMedicineFocus (optics)OncologyEGFR inhibitorsCancer researchEpidermal growth factor receptorInternal medicineCancerColorectal cancer
MeSH terms
CetuximabAntibodies, MonoclonalAntineoplastic AgentsClinical Trials as TopicCombined Modality TherapyHumansNeoplasmsAntibodies, Monoclonal, HumanizedErbB Receptors
Citations
557
FWCI
19.89
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Cited by
Cell death-based treatment of lung adenocarcinoma
Cell Death and Disease · 2018 · 781 citations
References
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
JNCI Journal of the National Cancer Institute · 1998 · 1,106 citations
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
JNCI Journal of the National Cancer Institute · 1999 · 1,064 citations
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
International Journal of Radiation Oncology*Biology*Physics · 2000 · 1,357 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.